Due to the high Trop‐2 expression as well as the consistent engraftment of primary END(K)265 tumor cells in SCID mice, these xenograft models were chosen for the in vivo experiments comparing the potential antitumor activity of SG, the control ADC, hRS7 IgG, and saline. Here, TACSTD2 is linked to neoplasm.